Hepatitis Monthly

Published by: Kowsar

Low Dose Ribavirin for Treatment of Hepatitis C Virus Infected Thalassemia Major Patients; New Indications for Combination Therapy

Seyed Vahid Tabatabaei 1 , Seyed Moayed Alavian 2 , * , Maryam Keshvari 1 , Bita Behnava 1 , Seyyed Mohammad Miri 1 , Pegah Karimi Elizee 1 , Farhad Zamani 1 , Sedigheh Amini Kafiabad 1 , Ahmad Gharehbaghian 1 , Bashir Hajibeigy 1 and Kamran Bagheri Lankarani 3
Authors Information
1 Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, IR Iran
2 Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, editor@hepatmon.com, IR Iran
3 Shiraz University of Medical Sciences, IR Iran
Article information
  • Hepatitis Monthly: , 12 (6); 372-381
  • Article Type: Research Article
  • Received: May 10, 2012
  • Accepted: May 30, 2012
  • DOI: 10.5812/hepatmon.6592

To Cite: Tabatabaei S, Alavian S, Keshvari M, Behnava B, Miri S, et al. Low Dose Ribavirin for Treatment of Hepatitis C Virus Infected Thalassemia Major Patients; New Indications for Combination Therapy, Hepat Mon. Online ahead of Print ;12(6):372-381. doi: 10.5812/hepatmon.6592.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments